TORONTO–(BUSINESS WIRE)–#LunarTime–Vartis Space Corp. today announced the launch of the Vartis Space Clock, a groundbreaking open-source…
Autor: Press Room
GlocalMe PetPhone “Pet Call Challenge” Sparkled on Hong Kong’s Avenue of Stars
HONG KONG–(BUSINESS WIRE)–The debut Pet Call Challenge, hosted by PetPhone, the first smartphone made for pets,…
LibertyStream and Packet Digital Sign MOU for U.S. Lithium Carbonate Supply Supporting Cathode Material Production for Next-Gen Battery and Power Systems in Military and Industrial Applications
LibertyStream Secures Approximately $2.7 Million in Gross Proceeds through a combination of non-dilutive grant funding and…
Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company,…
Nidec Announces Financial Results for Fiscal Second Quarter and Six Months Ended September 30, 2025
KYOTO, Japan–(BUSINESS WIRE)–Nidec Corporation (TOKYO:6594) (OTC US: NJDCY) today announced its consolidated financial results under the…
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
Sub-analysis of children with atopic dermatitis aged 2-17 in pivotal Phase 3 trials revealed early and…
American Gridwork Partners Acquires PMT Site to Accelerate Modernization of American’s National Grid Infrastructure Network
NASHVILLE, Tenn.–(BUSINESS WIRE)–American Gridwork Partners (AGP), a Legacy Holdings vehicle dedicated to modernizing America’s sub-regional and…
Kunming Is Becoming China’s Top Destination City for Inbound Consumption
KUNMING, China–(BUSINESS WIRE)–Positioned at the crossroads of the China–ASEAN Free Trade Area and the Greater Mekong…
OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”
KYOTO, Japan–(BUSINESS WIRE)–OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF…
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
Sub-analysis of children with atopic dermatitis aged 2-17 in pivotal Phase 3 trials revealed early and…